Sun Pharma beams up Organon in $11.75B acquisition
Sun Pharmaceutical is bringing Merck spinoff Organon into the fold, paying $11.75 billion in hopes of becoming a top global biosimilar player.
Read the full article on the original site.
Read Full Article